Last close As at 05/08/2026
—
— 0.00 (0.00%)
Market capitalisation
—
Research: TMT
Expert generated sales growth of 10% in FY19, slightly below guidance, and reported EBITDA at the midpoint of guidance. The company made good progress in shifting to subscription licensing (76% of licences sold) and reported its first sales via channel partners, which made up c 10% of sales. Reflecting the potential for COVID-19 to delay projects and new business, we have revised down our FY20 forecasts and assume an acceleration in revenue growth in FY21.
Expert System |
Focused on international growth |
FY19 results |
Software & comp services |
2 April 2020 |
Share price performance
Business description
Next events
Analyst
Expert System is a research client of Edison Investment Research Limited |
|||||||||||||||||||||||||||||||||||||||||||||
Expert System generated sales growth of 10% in FY19, slightly below guidance, and reported EBITDA at the midpoint of guidance. The company made good progress in shifting to subscription licensing (76% of licences sold) and reported its first sales via channel partners, which made up c 10% of sales. Reflecting the potential for COVID-19 to delay projects and new business, we have revised down our FY20 forecasts and assume an acceleration in revenue growth in FY21.
Year end |
Revenue (€m) |
EBITDA* |
EPS* |
DPS |
P/E |
EV/EBITDA |
12/18 |
30.5 |
4.6 |
(1.4) |
0.0 |
N/A |
18.8 |
12/19 |
33.7 |
5.5 |
(1.3) |
0.0 |
N/A |
16.0 |
12/20e |
35.5 |
5.1 |
(4.5) |
0.0 |
N/A |
17.2 |
12/21e |
39.7 |
6.9 |
(0.5) |
0.0 |
N/A |
12.6 |
Note: *EBITDA and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments.
FY19 EBITDA meets guidance
Expert System reported FY19 sales of €31.7m (+10% y-o-y), 4% below our forecast and company guidance. EBITDA of €5.5m was in the middle of Expert System’s guidance range and the company ended the year with a net debt position of €2.8m, down from €12.6m a year ago. Subscription licences were the driver of revenue growth, up 28% y-o-y, while perpetual licences and services were flat y-o-y. Recent management changes highlight Expert System’s desire to grow the business in the US and the company recently opened an office in Switzerland. The company has shifted to remote working to cope with COVID-19 restrictions and has made its Clinical Research Navigator tool available to medical researchers for free for the next three months to help in the effort to find treatments and a vaccine for the virus.
Factoring in COVID-19 disruption in FY20
Expert System has delayed the publication of its three-year strategic plan while dealing with the disruption from COVID-19. As we assume that there could be a delay in signing new business as well as some customers delaying the implementation of certain projects, we have reduced our FY20 sales forecast by 8%, which implies 7% growth y-o-y. Our cost forecasts are relatively unchanged (assuming continued investment in the US), resulting in a 33% cut to EBITDA. In FY21, we forecast a reacceleration in sales growth to 12.5% and 37% growth in EBITDA.
Valuation: Reflects growth potential
Compared to a diverse set of peers, Expert System is forecast to grow faster but is less profitable. Based on EV/Sales, it is trading at a premium to Italian peers and at a discount to all other peer groups. On an EV/EBITDA basis, it is trading at a premium to Italian and enterprise search and information management peers, and at a discount to data analytics peers. Evidence that recent investment is accelerating revenue growth would be a key driver of share price upside once a more normal business environment resumes. Progress towards operating profitability and cash generation should also provide support.
Review of FY19 results
Exhibit 1: FY19 results highlights
€m |
FY18a |
FY19e |
FY19a |
Diff |
y-o-y |
Sales |
28.7 |
33.0 |
31.7 |
(4.0%) |
10.3% |
Other income & grants |
1.8 |
1.5 |
2.1 |
37.2% |
17.0% |
Total revenues |
30.5 |
34.5 |
33.7 |
(2.2%) |
10.7% |
Capitalised development costs & changes in WIP |
5.1 |
5.1 |
6.0 |
18.0% |
19.1% |
Production value |
35.5 |
39.6 |
39.7 |
0.4% |
11.9% |
EBITDA |
4.6 |
5.6 |
5.5 |
(2.1%) |
17.7% |
EBITDA margin |
15.2% |
16.2% |
16.2% |
0.0% |
1.0% |
D&A |
(5.3) |
(5.7) |
(5.8) |
1.6% |
8.9% |
Normalised operating profit |
(0.7) |
(0.1) |
(0.3) |
202.1% |
(52.9%) |
Normalised operating margin |
(2.2%) |
(0.3%) |
(0.9%) |
(0.6%) |
1.2% |
Amortisation of acquired intangibles |
(2.6) |
(2.6) |
(2.6) |
0.0% |
0.0% |
Exceptional items |
0.0 |
0.0 |
0.0 |
0.0% |
N/A |
Reported operating profit |
(3.2) |
(2.7) |
(2.9) |
7.8% |
10.9% |
Exceptional items |
0.0 |
2.3 |
2.2 |
(5.3%) |
N/A |
Net financial income/(expense) |
0.1 |
(0.7) |
(0.1) |
(86.1%) |
N/A |
Normalised PBT |
(0.6) |
(0.8) |
(0.4) |
(50.6%) |
26.8% |
Reported PBT |
(3.1) |
(1.1) |
(0.8) |
(27.8%) |
75.1% |
Normalised net income |
(0.5) |
(0.8) |
(0.5) |
(30.8%) |
(2.5%) |
Reported net income |
(3.8) |
(1.0) |
(1.0) |
1.0% |
74.0% |
Diluted normalised EPS (c) |
(1.4) |
(1.9) |
(1.3) |
(30.8%) |
5.1% |
Net debt |
12.6 |
1.4 |
2.8 |
97.7% |
(77.5%) |
Source: Expert System, Edison Investment Research
Expert System reported sales of €31.7m for FY19, 10.3% higher y-o-y. This was 4% below our forecast and the company’s guidance of c €33m. Once other income & grants are included, total revenue reached €33.7m, +10.7% y-o-y and 2.2% below our forecast. EBITDA of €5.5m was at the midpoint of the company’s guidance (€5–6m). We note that this was after the capitalisation of €6.1m of development costs (versus our €5.1m forecast). Staff costs increased 1.2% y-o-y compared to our forecast for a 6.4% increase – the difference is explained by the higher rate of capitalisation of development costs. Other operating costs increased 25.8% y-o-y compared to our 15.7% forecast. We understand that more consultants were needed in H219 to complete several projects that had a year-end deadline.
Net financial expense was lower than forecast due to €0.4m in exchange rate gains. We have treated the €2.2m gain on disposal of Expert System’s stake in the ADmantX JV as an exceptional item.
Net debt at year-end was 78% lower than a year ago, helped by the €7m equity issuance in H119 and the sale of the ADmantX stake in November 2019. We note that the company had a gross cash balance of €21.6m at the end of FY19, with only a quarter of year-end debt due for repayment in FY20.
The shift to subscription licensing continues
The company reported that FY19 revenue was generated from Licences & Maintenance (61%), Services (36%) and Other (3%). Of licences sold, 76% were sold on a subscription basis, up from 72% in FY18 and 41% in FY17. We estimate that revenues from perpetual licence sales were effectively flat y-o-y, whereas subscription revenues increased c 28%. Revenues from services were also essentially flat y-o-y. We assume that maintenance revenues are gradually declining year-on-year as more customers opt for subscription licences.
While the company has been keen to shift licensing over to subscription, it has typically delivered the software on-premise or in the private cloud. It is planning to launch a new SaaS platform that will enable customers to deploy the software in the public cloud.
Work developing the channel starting to bear fruit
Over the last year, the company increased its efforts to attract and support channel partners. Its training and certification programme attracted 500 professionals from more than 40 companies covering more than 25 countries. The company has targeted global system integrators, global consulting firms and local mid-size players. In FY19, this resulted in c €3m/10% of revenues being generated via partners.
Key deals generated via the channel include:
■
multi-year defence programmes in two EU countries;
■
an automation project for an EU primary bank; and
■
an automation project for a UK government agency.
Technology update
The company refined its product offerings for its core insurance and finance markets. It released Cogito 14.5, which improved the performance of Arabic and Dutch language understanding. Expert System also successfully integrated its software with software from various third-party robotic process automation (RPA) vendors to support intelligent process automation.
Management changes reflect focus on US growth
In February, the company announced that it had appointed a new group CEO, Walt Mayo. Walt is based in the US and has a background of helping businesses to scale up. In March, the company announced that it had hired a COO, Gabriele Donino, who most recently headed up Digital and AI Solutions for Swiss Re. Stefano Spaggiari, one of Expert System’s founders and the previous CEO, is moving to the role of CEO of the Italian business.
Targeting growth outside Italy
In FY19, revenues generated in Italy grew 15% y-o-y, were flat in the rest of Europe (although France grew 41% y-o-y) and grew 15% in the US. The company is keen to expand its presence in the US and plans to focus on the key verticals of Bank & Insurance and Information/Publishing/ Media. Expert System has also opened an office in Switzerland.
COVID-19 response
As an Italy-headquartered company, Expert System moved to remote working as soon as the lockdown started in Italy. Many of its teams around the world already operate for much of the time on a remote basis so this has not been a big shift in behaviour for staff.
From a customer perspective, some are looking to delay certain projects, and we would expect signing up new business in the current environment to be more difficult.
From a product perspective, the company has made its Clinical Research Navigator (CRN) tool available to medical researchers to search, filter and cross-reference critical information against every major clinical trial registry, publications database, funder research and social media streams (https://www.youtube.com/watch?v=FxrFldY9hkg). Expert System is offering biomedical researchers worldwide free access to the tool until 1 July. Expert System’s CRN tool is available as a cloud-based SaaS application, and is able to aggregate information from multiple sources and structure the content in an intuitive user interface.
Strategic focus for FY20
The company’s focus for FY20 includes:
■
US push: invest in sales, marketing and customer success for the US corporate market, focusing on the insurance, finance, and information/publishing/media sectors.
■
Grow the partner channel: accelerate the reach of the partner network, including select global system integrators, and local vertically and AI/RPA-focused vendors.
■
Develop OEM relationships: the company wants to work with software companies involved in cognitive search, sales & marketing augmented insight, and point solutions that depend on language understanding in order to provide Expert System’s language understanding layer in their stack.
■
Accelerate shift in licensing: Expert System wants to accelerate adoption of annual recurring and consumption-based pricing with existing and new customers.
■
Strengthen delivery capabilities: the company is planning to strengthen and optimise its delivery and professional services functions to support scaling up the business.
Outlook and changes to forecasts
In the current environment, management has decided to delay publishing its next three-year strategy plan (the previous one ran to FY19). We have reduced our revenue forecasts, reflecting both the lower base in FY19 and a lower rate of growth in FY20. We leave our cost forecasts substantially unchanged, reflecting the continuing investment in the US, resulting in a reduction in our EBITDA forecast for FY20. This investment should, however, support growth in the longer run and we factor in accelerating growth in FY21.
Exhibit 2: Changes to forecasts
€m |
FY20e old |
FY20e new |
Change |
y-o-y |
FY21e new |
y-o-y |
Sales |
37.0 |
34.0 |
(8.3%) |
7.3% |
38.2 |
12.5% |
Other income & grants |
1.5 |
1.5 |
0.0% |
(27.1%) |
1.5 |
0.0% |
Total revenues |
38.5 |
35.5 |
(8.0%) |
5.2% |
39.7 |
11.9% |
Capitalised development costs & changes in WIP |
5.2 |
6.1 |
17.3% |
1.3% |
6.1 |
0.0% |
Production value |
43.7 |
41.6 |
(5.0%) |
4.6% |
45.8 |
10.2% |
EBITDA |
7.6 |
5.1 |
(32.9%) |
(7.1%) |
6.9 |
36.8% |
EBITDA margin |
19.6% |
14.3% |
(5.3%) |
(1.9%) |
17.5% |
3.2% |
D&A |
(6.0) |
(6.3) |
4.3% |
(6.4) |
||
Normalised operating profit |
1.5 |
(1.2) |
(177.6%) |
285.0% |
0.6 |
(146.9%) |
Normalised operating margin |
4.0% |
(3.4%) |
(7.4%) |
(2.5%) |
1.4% |
4.8% |
Amortisation of acquired intangibles |
(0.9) |
(0.9) |
0.0 |
|||
Exceptional items |
0.0 |
0.0 |
0.0 |
|||
Reported operating profit |
0.7 |
(2.1) |
(397.3%) |
N/A |
0.6 |
N/A |
Normalised net income |
0.7 |
(1.8) |
242.3% |
(0.2) |
(88.9%) |
|
Reported net income |
(0.1) |
(2.6) |
(159.7%) |
(0.2) |
92.3% |
|
Diluted normalised EPS (c) |
1.6 |
(4.5) |
(370.4%) |
(230.5%) |
(0.5) |
88.9% |
Net debt |
2.2 |
7.2 |
219.7% |
153.2% |
9.9 |
38.0% |
Source: Edison Investment Research
Valuation
Most of Expert System’s direct competitors are private companies or subsidiaries of large companies such as IBM or Micro Focus. We have compared Expert System’s valuation and operating metrics to peers operating in the natural language processing, big data analytics, enterprise search and information management markets, as well as to Italian software and IT services peers.
Based on EV/Sales, Expert System is trading at a premium to Italian peers and at a discount to all other peer groups, with forecast revenue growth towards the upper end of the group. On an EV/EBITDA basis, Expert System is trading at a premium to Italian and enterprise search and information management peers, and at a discount to data analytics peers. Evidence that the recent investment in sales and support is driving accelerating revenue growth would be a key driver for share price upside. Progress towards net cash generation and operating profitability should provide key support to the share price.
Exhibit 3: Peer group metrics
Year |
Market cap |
CY EV/ |
NY EV/Sales |
CY EV/ |
NY EV/ |
CY P/E |
NY P/E |
CY sales (€m) |
CY |
CY EBITDA margin |
Sales growth NY |
EPS growth NY |
|
Natural Language Understanding |
|
|
|
|
|
|
|
||||||
Expert System |
Dec-20 |
84 |
2.5x |
2.2x |
17.2x |
12.6x |
N/A |
N/A |
35.5 |
-3.4% |
14.3% |
11.9% |
N/A |
Nuance Communications |
Sep-20 |
4,546 |
3.8x |
3.7x |
14.1x |
13.1x |
19.0x |
17.5x |
1,360 |
23.6% |
27.0% |
3.5% |
8.7% |
Big Data Analytics |
|||||||||||||
Splunk |
Jan-20 |
15,813 |
7.3x |
6.0x |
44.6x |
32.8x |
61.6x |
49.6x |
2,047 |
14.4% |
16.4% |
21.8% |
24.2% |
Teradata |
Dec-19 |
3,119 |
1.8x |
1.7x |
9.1x |
7.6x |
20.8x |
14.8x |
1,750 |
12.0% |
19.3% |
3.0% |
40.7% |
Average |
4.5x |
3.9x |
26.9x |
20.2x |
41.2x |
32.2x |
13.2% |
17.9% |
12.4% |
32.4% |
|||
Enterprise search and information management |
|||||||||||||
OpenText |
Jun-20 |
11,311 |
3.7x |
3.4x |
10.2x |
8.9x |
11.5x |
10.0x |
2,860 |
33.9% |
35.1% |
9.3% |
15.2% |
IHS Markit |
Nov-20 |
21,415 |
6.7x |
6.3x |
15.7x |
14.4x |
21.4x |
18.9x |
3,909 |
37.6% |
39.1% |
6.3% |
13.4% |
Elastic |
Apr-20 |
3,984 |
9.7x |
7.3x |
N/A |
N/A |
N/A |
N/A |
382 |
-20.5% |
-16.9% |
32.6% |
17.5% |
CommVault |
Mar-20 |
1,623 |
2.1x |
2.1x |
12.9x |
11.9x |
24.4x |
24.2x |
619 |
13.9% |
14.2% |
2.0% |
0.8% |
Average |
5.6x |
4.8x |
12.9x |
11.7x |
19.1x |
17.7x |
16.2% |
17.8% |
12.6% |
11.7% |
|||
Italian software & services |
|||||||||||||
TXT e-solutions |
Dec-20 |
80 |
0.6x |
0.6x |
7.0x |
5.2x |
16.3x |
N/A |
63 |
10.0% |
5.9% |
7.9% |
N/A |
Exprivia |
Dec-19 |
36 |
0.5x |
0.4x |
7.4x |
5.8x |
N/A |
7.0x |
560 |
2.9% |
4.3% |
7.9% |
N/A |
Piteco |
Dec-19 |
96 |
4.8x |
4.6x |
11.3x |
11.1x |
16.4x |
16.0x |
24 |
31.2% |
42.6% |
5.0% |
2.3% |
Reply |
Dec-20 |
1,925 |
1.5x |
1.3x |
9.3x |
8.5x |
16.9x |
15.4x |
1,253 |
12.7% |
13.0% |
8.4% |
10.0% |
Average |
1.8x |
1.7x |
8.8x |
7.7x |
16.5x |
12.8x |
14.2% |
16.5% |
7.3% |
6.2% |
|||
Source: Edison Investment Research, Refinitiv (as at 30 March).
We have performed a reverse DCF to calculate the growth and profitability that is factored into the share price beyond our forecast period. We estimate that the share price is factoring in a revenue CAGR of 12.5% from FY22 to FY29, with EBITDA margins rising to 29.5% by FY29. Assuming the company continues to capitalise development spend, we forecast capex/sales reducing to 9.4% by FY29, with a terminal EBIT margin of 20% (in line with established software companies). We use a WACC of 8% and long-term growth of 3%. A 1% increase in the WACC results in a valuation of €1.85/share, whereas a 1% decrease results in a valuation of €3.29.
Exhibit 4: Financial summary
€'000s |
2015 |
2016 |
2017 |
2018 |
2019 |
2020e |
2021e |
||
31-December |
IT GAAP |
IT GAAP |
IT GAAP |
IT GAAP |
IT GAAP |
IT GAAP |
IT GAAP |
||
PROFIT & LOSS |
|||||||||
Revenue |
|
|
19,368 |
25,057 |
27,783 |
30,457 |
33,712 |
35,465 |
39,702 |
EBITDA |
|
|
1,463 |
(2,245) |
1,711 |
4,638 |
5,459 |
5,069 |
6,933 |
Operating Profit (before amort. and except.) |
(1,226) |
(5,941) |
(3,189) |
(662) |
(312) |
(1,199) |
563 |
||
Intangible Amortisation |
(2,549) |
(2,608) |
(2,608) |
(2,567) |
(2,567) |
(855) |
0 |
||
Exceptionals |
0 |
0 |
(700) |
0 |
0 |
0 |
0 |
||
Other |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||
Operating Profit |
(3,775) |
(8,549) |
(6,496) |
(3,229) |
(2.878) |
(2,054) |
563 |
||
Net Interest |
213 |
(156) |
(2,191) |
97 |
(102) |
(782) |
(782) |
||
Profit Before Tax (norm) |
|
|
(1,013) |
(6,097) |
(5,380) |
(565) |
(413) |
(1,981) |
(219) |
Profit Before Tax (reported) |
|
|
(3,562) |
(8,705) |
(8,687) |
(3,131) |
(780) |
(2,836) |
(219) |
Tax |
277 |
579 |
348 |
(650) |
(203) |
284 |
22 |
||
Profit After Tax (norm) |
(934) |
(5,692) |
(5,164) |
(508) |
(521) |
(1,783) |
(197) |
||
Profit After Tax (reported) |
(3,284) |
(8,126) |
(8,339) |
(3,781) |
(983) |
(2,553) |
(197) |
||
Average Number of Shares Outstanding (m) |
22.8 |
25.8 |
28.1 |
35.8 |
38.6 |
40.0 |
40.0 |
||
EPS - normalised (c) |
|
|
(4.1) |
(22.0) |
(18.3) |
(1.4) |
(1.3) |
(4.5) |
(0.5) |
EPS - normalised and fully diluted (c) |
|
(4.1) |
(22.0) |
(18.3) |
(1.4) |
(1.3) |
(4.5) |
(0.5) |
|
EPS - (IFRS) (c) |
|
|
(14.4) |
(31.5) |
(29.6) |
(10.6) |
(2.5) |
(6.4) |
(0.5) |
Dividend per share (c) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
||
EBITDA Margin (%) |
7.6 |
-9.0 |
6.2 |
15.2 |
16.2 |
14.3 |
17.5 |
||
Adj Operating Margin (%) |
-6.3 |
-23.7 |
-11.5 |
-2.2 |
-0.9 |
-3.4 |
1.4 |
||
BALANCE SHEET |
|||||||||
Fixed Assets |
|
|
20,301 |
20,379 |
18,864 |
16,655 |
14,708 |
14,185 |
14,415 |
Intangible Assets |
18,539 |
18,372 |
16,944 |
14,734 |
13,092 |
12,582 |
12,839 |
||
Tangible Assets |
916 |
915 |
792 |
715 |
702 |
689 |
661 |
||
Investments |
846 |
1,092 |
1,128 |
1,206 |
915 |
915 |
915 |
||
Current Assets |
|
|
42,588 |
37,012 |
37,634 |
38,004 |
51,495 |
49,890 |
49,930 |
Stocks |
1,797 |
627 |
99 |
109 |
59 |
59 |
59 |
||
Debtors |
10,228 |
10,233 |
12,384 |
15,792 |
20,447 |
22,901 |
25,649 |
||
Cash |
11,249 |
9,063 |
11,235 |
7,883 |
21,647 |
17,305 |
14,575 |
||
Other |
19,314 |
17,088 |
13,916 |
14,220 |
9,342 |
9,626 |
9,648 |
||
Current Liabilities |
|
|
(20,517) |
(22,679) |
(19,480) |
(21,170) |
(22,839) |
(23,264) |
(23,731) |
Creditors |
(15,082) |
(16,459) |
(14,104) |
(15,511) |
(16,945) |
(17,370) |
(17,837) |
||
Short term borrowings |
(5,435) |
(6,219) |
(5,376) |
(5,659) |
(5,893) |
(5,893) |
(5,893) |
||
Long Term Liabilities |
|
|
(22,227) |
(18,275) |
(17,742) |
(18,411) |
(22,464) |
(22,464) |
(22,464) |
Long term borrowings |
(18,240) |
(15,252) |
(14,683) |
(14,811) |
(18,588) |
(18,588) |
(18,588) |
||
Other long term liabilities |
(3,987) |
(3,023) |
(3,060) |
(3,600) |
(3,876) |
(3,876) |
(3,876) |
||
Net Assets |
|
|
20,145 |
16,437 |
19,276 |
15,077 |
20,901 |
18,348 |
18,151 |
CASH FLOW |
|||||||||
Operating Cash Flow |
|
|
2,738 |
2,088 |
(1,921) |
2,583 |
3,144 |
3,016 |
4,628 |
Net Interest |
(324) |
(155) |
(626) |
(441) |
(694) |
(758) |
(758) |
||
Tax |
(1,576) |
0 |
0 |
0 |
0 |
0 |
0 |
||
Capex |
(20,045) |
(6,378) |
(6,321) |
(5,830) |
(6,401) |
(6,600) |
(6,600) |
||
Acquisitions/disposals |
3,045 |
46 |
1,275 |
(76) |
7,189 |
0 |
0 |
||
Financing |
6,573 |
4,418 |
11,178 |
0 |
7,000 |
0 |
0 |
||
Dividends |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||
Net Cash Flow |
(9,588) |
18 |
3,585 |
(3,764) |
10,237 |
(4,342) |
(2,730) |
||
Opening net debt/(cash) |
|
|
2,839 |
12,426 |
12,408 |
8,824 |
12,587 |
2,834 |
7,176 |
HP finance leases initiated |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||
Other |
0 |
0 |
0 |
0 |
(484) |
0 |
(0) |
||
Closing net debt/(cash) |
|
|
12,426 |
12,408 |
8,824 |
12,587 |
2,834 |
7,176 |
9,906 |
Source: Expert System, Edison Investment Research
|
|
Research: Investment Companies
Launched in 1989, Genesis Emerging Markets Fund (GSS) is one of the first UK-listed funds focused on investing in equities in emerging and developing countries. Its primary objective is to deliver long-term capital growth through a bottom-up approach to investing in high-quality companies with sustainable earnings growth. GSS has a solid performance track record, and has outperformed its benchmark over one, three, five and 10 years to end-February. Emerging markets equities have suffered a significant setback in response to the COVID-19 pandemic and the fund’s discount to NAV is wider than average, which may present an opportunity for long-term investors.